[Madreporic hydroxyapatite granulates for filling bone defects].
Two macrocrystalline madreporic granular hydroxyapatite implants of different size range (single crystal size within both implants 1-3 microns) were implanted for 7, 28, 84 and 168 days into the trabecular bone of the distal femur epiphysis of rabbits. Both materials were investigated histologically. For testing of granular materials a new animal model has been developed. The drill hole was closed by reimplantation of an autologeous chondrocortical tissue slice to prevent loss of particles into the knee-joint. Both of the granular materials tested developed increasing bone bonding from the 7th day on to outer surfaces and pore surfaces. The degradation of both of the materials affected the superficial implant layers in soft-tissue interfaces exclusively and was mainly due to passive processes, e.g. leaching, fragmentation of granules after crack-production, particulate degradation and subsequent phagocytosis of liberated implant particles by macrophages and foreign body giant cells. Zones of superficial implant degradation were bonded partially to bone a second time. A possible low-degree, active superficial degradation by foreign body giant cells is discussed. Osteoclasts of typical morphology as being observed on other hydroxyapatite implant surfaces were not demonstrated. This was related to the low degradation rate of the implants. Both of the granular materials tested are useful in filling bone defects. A guided tissue regeneration due to partial implant degradation and subsequent bone formation seems to be impossible since the degradation rate of the materials is too low.
Müller-Mai
C
C
Labor für Biomaterialforschung, Klinik für Unfall- und Wiederherstellungschirurgie, Universitätsklinikum Benjamin Franklin, Freie Universität Berlin, Hindenburgdamm 30, 12200 Berlin.
Voigt
C
C
Hering
A
A
Rahmanzadeh
R
R
Gross
U
U
D000818:Animals; D001672:Biocompatible Materials / Q000009:adverse effects; D018786:Bone Substitutes / Q000009:adverse effects; D017886:Durapatite / Q000009:adverse effects; D004838:Epiphyses / Q000601:surgery; D005260:Female; D005269:Femur / Q000601:surgery; D005549:Foreign-Body Reaction / Q000209:etiology; D010316:Particle Size; D011817:Rabbits; D013997:Time Factors
D001672:Biocompatible Materials; D018786:Bone Substitutes; C104266:endobon; D017886:Durapatite